Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by grumpymonkey007on Nov 13, 2013 8:59pm
376 Views
Post# 21904043

All in sustaining costs definition

All in sustaining costs definition
from the world gold council:

Guidance note on non-gaap metrics – all-in sustaining costs and all-in costs

 

 

US $ / gold  ounces sold

 

 

 

On-Site Mining Costs (on a sales basis)

Income Statement

(a)

On-Site General & Administrative costs

Income Statement

(b)

Royalties & Production Taxes

Income Statement

(c)

Realised Gains/Losses on Hedges due to operating costs

Income Statement

(d)

Community Costs related to current operations

Income Statement

(e)

Permitting Costs related to current operations

Income Statement

(f)

3rd party smelting, refining and transport costs

Income Statement

(g)

Non-Cash Remuneration (Site-Based)

Income Statement

(h)

Stock-piles / product inventory write down

Income Statement

(i)

Operational Stripping Costs

Income Statement

(j)

By-Product Credits

Income Statement

(k) Note: this will be a credit

Sub-Total (Adjusted Operating Costs)

 

(l) = (a) + (b) + (c) + (d) + (e) + (f) + (g) + (h) + (i) + (j) + (k)

 

 

 

Corporate General & Administrative costs (including share-based remuneration)

Income Statement

(m)

Reclamation & remediation – accretion & amortisation (operating sites)

Income Statement

(n)

Exploration and study costs (sustaining)

Income Statement

(o)

Capital exploration (sustaining)

Cash  Flow

(p)

Capitalised stripping & underground mine development (sustaining)

Cash Flow

(q)

Capital expenditure (sustaining)

Cash Flow

(r)

All-in Sustaining Costs

 

(s) = (l) + (m) + (n) + (o) + (p) + (q) + (r)

 

 

 

Community Costs not related to current operations

Income Statement

(t)

Permitting Costs not related to current operations

Income Statement

(u)

Reclamation and remediation costs not related to current operations

Income Statement

(v)

Exploration and study costs (non-sustaining)

Income Statement

(w)

Capital exploration (non-sustaining)

Cash Flow

(x)

Capitalised stripping & underground mine development (non-sustaining)

Cash Flow

(y)

Capital expenditure (non-sustaining)

Cash Flow

(z)

 

 

 

All-in Costs

 

 = (s) + (t) + (u) + (v) + (w) + (x) + (y) + (z)

Bullboard Posts